Research Topic · Peer-Reviewed

Cancer Clinical Trials

Cancer clinical trials are prospective research studies that evaluate new methods to prevent, detect, diagnose, or treat malignancy, generating the evidence needed to establish whether an intervention is safe and effective before it enters routine practice. They are organised into sequential phases that progress fro…

Curated from this journal's research 📚 8 peer-reviewed articles cited Cited 15× across the literature 🔖 ISSN 2572-3030 🗓 Reviewed June 2026

Overview

Cancer clinical trials are prospective research studies that evaluate new methods to prevent, detect, diagnose, or treat malignancy, generating the evidence needed to establish whether an intervention is safe and effective before it enters routine practice. They are organised into sequential phases that progress from early assessment of safety and dosing to comparative evaluation of efficacy against existing standards, and they increasingly incorporate biomarker-driven and targeted designs. Translational platforms underpin this work: high-throughput disease-modelling systems developed for ethical drug discovery and biomarker development illustrate how preclinical models inform trial-ready candidates, while immunoassays and immunogenomic monitoring provide endpoints for tracking response. Trials in specific malignancies, such as evaluations of targeted antibody therapy in HER2-positive gastric cancer and proposed methods for prevention, screening, and management of lung cancer, demonstrate how novel techniques and agents are tested across diagnosis and treatment. Investigations of molecular regulators and of repurposed agents, including studies of statins and heparin in lung cancer and of pharmacological prevention in colorectal cancer, exemplify hypotheses that trials are designed to test. By systematically comparing interventions under controlled conditions and capturing molecular, clinical, and survival outcomes, cancer clinical trials translate laboratory findings into validated therapies, refine prevention and screening strategies, and provide the rigorous foundation on which modern oncology practice depends.

Research published in this journal

8 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 8 articles above have been cited 15 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Cancer Clinical Trials, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Cancer Genetics And Biomarkers (ISSN 2572-3030).

Journal editorial board
Dr. Charlie Gourley · United Kingdom Dr. Xinyu Chen · United States Dr. Guru Prasad Maiti · United States

This page summarises published research for orientation; it is not medical or professional advice.